| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience, Inc.
|
Jun 26, 2026 | BUY |
Strong Buy
+15.6% avg upside
13 analysts
|
$44.00
67.87% Upside
|
-8.4% |
|
ATAI
Atai Beckley N.V.
|
Jun 25, 2026 | BUY |
Strong Buy
+170.4% avg upside
16 analysts
|
$16.00
222.64% Upside
|
+6.6% |
|
DFTX
Definium Therapeutics
|
Jun 23, 2026 | BUY |
Strong Buy
-6.2% avg upside
20 analysts
|
$74.00
67.00% Upside
|
+22.1% |
|
PRAX
Praxis Precision Medicines
|
Jun 02, 2026 | BUY |
Strong Buy
+68.7% avg upside
24 analysts
|
$441.00
40.60% Upside
|
+21.5% |
|
BLRX
Bioline RX Ltd Sponsored ADR
|
Jun 02, 2026 | BUY |
Strong Buy
+229.8% avg upside
6 analysts
|
$12.00
280.17% Upside
|
· |
|
VNRX
VolitionRX
|
May 18, 2026 | BUY |
Strong Buy
+582.5% avg upside
11 analysts
|
$24.00
1677.78% Upside
|
+0.0% |
|
SER
Serina Therapeutics
|
May 18, 2026 | BUY |
Strong Buy
+481.1% avg upside
3 analysts
|
$11.00
464.07% Upside
|
+21.9% |
|
CLNN
Clene
|
May 15, 2026 | BUY |
Strong Buy
+441.8% avg upside
11 analysts
|
$30.00
399.15% Upside
|
+0.0% |
|
RNXT
RenovoRx
|
May 15, 2026 | BUY |
Strong Buy
+575.3% avg upside
5 analysts
|
$8.00
744.16% Upside
|
+10.8% |
|
CATX
Perspective Therapeutics
|
May 14, 2026 | BUY |
Strong Buy
+210.2% avg upside
22 analysts
|
$18.00
398.59% Upside
|
-8.0% |
|
NMTC
NeuroOne Medical Technologies
|
May 13, 2026 | BUY |
Strong Buy
+162.5% avg upside
5 analysts
|
$8.00
158.95% Upside
|
· |
|
TLSI
TriSalus Life Sciences
|
May 13, 2026 | BUY |
Strong Buy
+114.0% avg upside
8 analysts
|
$11.00
155.22% Upside
|
+0.4% |
|
ACHV
Achieve Life Sciences
|
May 12, 2026 | BUY |
Strong Buy
+139.8% avg upside
13 analysts
|
$20.00
210.04% Upside
|
+6.8% |
|
LNTH
Lantheus
|
May 08, 2026 | HOLD |
Strong Buy
-27.5% avg upside
20 analysts
|
— | +8.5% |
|
RAPP
Rapport Therapeutics, Inc.
|
May 07, 2026 | BUY |
Strong Buy
+40.2% avg upside
13 analysts
|
$50.00
29.63% Upside
|
-3.4% |
|
ATNM
Actinium Pharmaceuticals
|
Apr 02, 2026 | BUY |
Strong Buy
+686.2% avg upside
11 analysts
|
$9.00
836.54% Upside
|
+19.4% |
|
RADX
Radiopharm Theranostics Limited Sponsored ADR
|
Mar 25, 2026 | BUY |
Strong Buy
+321.3% avg upside
6 analysts
|
$30.00
589.74% Upside
|
+9.2% |
|
XAIR
Beyond Air
|
Mar 11, 2026 | BUY |
Strong Buy
+4596.8% avg upside
10 analysts
|
$2.00
355.50% Upside
|
-42.1% |
|
VOR
Vor Biopharma
|
Jan 05, 2026 | HOLD |
Buy
+118.1% avg upside
17 analysts
|
— | +90.0% |
|
MNPR
Monopar Therapeutics Inc
|
May 14, 2025 | HOLD |
Strong Buy
+2.1% avg upside
18 analysts
|
— | +59.7% |
|
PSTV
Plus Therapeutics
|
Mar 21, 2025 | HOLD |
Strong Buy
+708.4% avg upside
11 analysts
|
— | -81.6% |
|
AU:RAD
Radiopharm Theranostics Limited
|
Oct 30, 2024 | BUY |
Strong Buy
+1900.0% avg upside
1 analyst
|
$0.40
1899.95% Upside
|
· |
|
PRME
Prime Medicine, Inc.
|
Aug 08, 2024 | BUY |
Strong Buy
+144.9% avg upside
16 analysts
|
$20.00
401.24% Upside
|
-15.2% |
|
QUCY
Quantum Cyber
|
Jun 04, 2024 | BUY |
Buy
+177.7% avg upside
4 analysts
|
$4.00
177.73% Upside
|
· |
|
CRIS
Curis
|
Jun 06, 2022 | BUY |
Strong Buy
+43.5% avg upside
12 analysts
|
$10.00
68.26% Upside
|
-44.4% |
|
GTBP
GT Biopharma
|
May 19, 2022 | BUY |
Strong Buy
+2043.6% avg upside
3 analysts
|
$18.00
3575.06% Upside
|
-96.1% |
|
HROW
Harrow Health
|
May 19, 2022 | BUY |
Strong Buy
+19.7% avg upside
12 analysts
|
$20.00
55.51% Downside
|
+190.5% |
|
CMPX
Compass Therapeutics
|
May 10, 2022 | BUY |
Strong Buy
+321.1% avg upside
19 analysts
|
$10.00
336.78% Upside
|
+2614.6% |
|
CTSO
Cytosorbents
|
May 04, 2022 | BUY |
Strong Buy
+2659.6% avg upside
13 analysts
|
$6.00
1295.30% Upside
|
-58.5% |
|
ETON
Eton Pharmaceuticals
|
Apr 07, 2022 | BUY |
Strong Buy
-33.0% avg upside
8 analysts
|
$10.00
73.60% Downside
|
-14.5% |
|
VRAYQ
Viewray
|
Jan 11, 2022 | BUY |
Strong Buy
+558333233.3% avg upside
12 analysts
|
$7.00
699999899.99% Upside
|
-100.0% |
|
FOCL
EDAP TMS
|
Nov 26, 2021 | HOLD |
Buy
+30.9% avg upside
7 analysts
|
— | · |
|
PGEN
Precigen
|
Nov 26, 2021 | HOLD |
Strong Buy
+333.2% avg upside
11 analysts
|
— | -70.0% |
|
SNDX
Syndax Pharmaceuticals
|
Nov 17, 2021 | BUY |
Strong Buy
+62.7% avg upside
27 analysts
|
$30.00
35.96% Upside
|
-14.3% |
|
ALP
Alpha Compute
|
Sep 02, 2021 | BUY |
Strong Buy
+8009.2% avg upside
6 analysts
|
$40.00
15957.78% Upside
|
· |
|
GERN
Geron
|
Feb 17, 2021 | BUY |
Strong Buy
+197.0% avg upside
19 analysts
|
$4.00
177.72% Upside
|
+41.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.